Quote | Cara Therapeutics Inc. (NASDAQ:CARA)
|Last Trade Date Time:||09/28/2023 03:00:00 am|
News | Cara Therapeutics Inc. (NASDAQ:CARA)
Commercial-stage biopharma, Cara Therapeutics ( NASDAQ: CARA ) announced on Thursday that the company’s lead product difelikefalin reached the primary endpoint in a Phase 2 trial designed to evaluate it in pruritus in patients with notalgia paresthetica (NP). NP is ...
Message Board Posts | Cara Therapeutics Inc. (NASDAQ:CARA)
|Yeah, good entry room for upwards momentum?||WallStreetMyWay||investorshub||04/12/2022 4:05:19 PM|
|Moving up saved its nice growing money nows||WallStreetMyWay||investorshub||04/12/2022 4:02:57 PM|
|Got some bounce today.||a surfer||investorshub||03/02/2022 9:15:22 PM|
|https://www.benzinga.com/news/earnings/21/11/24060763/you-ask-we-analyze-why-sun||BottomBounce||investorshub||11/16/2021 4:03:01 PM|
|$CARA chart||conix||investorshub||11/15/2021 11:25:36 PM|
Cara Therapeutics Inc. Company Name:
CARA Stock Symbol:
Cara Therapeutics Inc. Website:
Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 111% to $0.4000. Avinger, Inc. (NASDAQ: AVGR) surged 63.2% to $6.75 amid the company announcing...
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results. AERWINS Technolo...
STAMFORD, Conn., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (NASDAQ:CARA), a commercial-stage biopharmaceutical company leading...